RT Book, Section
A1 Deininger, Michael W.N.
A1 Druker, Brian J.
A2 Boyiadzis, Michael M.
A2 Frame, James N.
A2 Kohler, David R.
A2 Fojo, Tito
SR Print(0)
ID 1128253795
T1 Leukemia, Chronic Myelogenous
T2 Hematology-Oncology Therapy, 2e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071637893
LK hemonc.mhmedical.com/content.aspx?aid=1128253795
RD 2024/04/23
AB EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence:5,980  (male:  3,130;  female:  2,850.Phase  at  presentation:Estimated  new  cases  for  2014  in  the  United  States)Chronic  phase:  85–90%Deaths:Estimated  810  in  2014  (male:  550;  female:  260)Accelerated  phase  and  blast  crisis:  10–15%Median  age:65  years  Male  to  female  ratio:1.7:1  Cervantes  F  et  al.  Haematologica  1999;84:324–327O'Brien  SG  et  al.  N  Engl  J  Med  2003;348:994–1004Siegel  R  et  al.  CA  Cancer  J  Clin  2014;64:9–29Surveillance,  Epidemiology  and  End  Results  (SEER)  Program,  available  from  http://seer.cancer.gov  (accessed  in  2013)